MA40636A - Procédés pour détecter le cancer de la prostate - Google Patents

Procédés pour détecter le cancer de la prostate

Info

Publication number
MA40636A
MA40636A MA040636A MA40636A MA40636A MA 40636 A MA40636 A MA 40636A MA 040636 A MA040636 A MA 040636A MA 40636 A MA40636 A MA 40636A MA 40636 A MA40636 A MA 40636A
Authority
MA
Morocco
Prior art keywords
prostate cancer
methods
detect prostate
detect
prognosis
Prior art date
Application number
MA040636A
Other languages
English (en)
Inventor
Colleen Kelly
Harry Stylli
Original Assignee
Colleen Kelly
Harry Stylli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colleen Kelly, Harry Stylli filed Critical Colleen Kelly
Publication of MA40636A publication Critical patent/MA40636A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

La présente invention concerne des marqueurs biologiques pour le diagnostic, le pronostic et la surveillance du cancer de la prostate
MA040636A 2014-09-11 2015-09-11 Procédés pour détecter le cancer de la prostate MA40636A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462049281P 2014-09-11 2014-09-11

Publications (1)

Publication Number Publication Date
MA40636A true MA40636A (fr) 2015-09-11

Family

ID=55459625

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040636A MA40636A (fr) 2014-09-11 2015-09-11 Procédés pour détecter le cancer de la prostate

Country Status (5)

Country Link
US (2) US10626464B2 (fr)
EP (4) EP3693742B1 (fr)
AU (2) AU2015314813B2 (fr)
MA (1) MA40636A (fr)
WO (1) WO2016040843A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (fr) 2013-03-09 2014-10-09 Harry Stylli Procédés de détection du cancer de la prostate
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
CA3108159A1 (fr) * 2018-07-31 2020-02-06 Immunis.Ai, Inc. Compositions et procedes de detection du cancer de la prostate
KR102195895B1 (ko) * 2019-04-19 2020-12-28 한국생명공학연구원 STT(2-(5-Methyl-4-oxo-2-thioxo-1,3-thiazolidin-3-yl) ethanesulfonic acid))를 유효성분으로 포함하는 파킨슨병 예방 또는 치료용 약학적 조성물
CN110609141A (zh) * 2019-09-30 2019-12-24 中山大学孙逸仙纪念医院 Gltscr1前列腺癌预后检测试剂及其试剂盒

Family Cites Families (255)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4868103A (en) 1986-02-19 1989-09-19 Enzo Biochem, Inc. Analyte detection by means of energy transfer
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US5459039A (en) 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
EP0552108B1 (fr) 1992-01-17 1999-11-10 Lakowicz, Joseph R. Essai fluoro-immunologique impliquant un transfert d'énergie par phase-modulation
DE69433811T2 (de) 1993-01-07 2005-06-23 Sequenom, Inc., San Diego Dns - sequenzierung durch massenspektronomie
WO1994021686A1 (fr) 1993-03-19 1994-09-29 Northern Sydney Area Health Service Papp-a, son immunodetection et ses utilisations
US5594637A (en) 1993-05-26 1997-01-14 Base Ten Systems, Inc. System and method for assessing medical risk
US5498531A (en) 1993-09-10 1996-03-12 President And Fellows Of Harvard College Intron-mediated recombinant techniques and reagents
US5514598A (en) 1993-11-30 1996-05-07 Doody; Michael Prenatal detection of meconium
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US6031088A (en) 1996-05-23 2000-02-29 Albert Einstein College Of Medicine Of Yeshiva University Polycystic kidney disease PKD2 gene and uses thereof
GB9704444D0 (en) 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
US20010051341A1 (en) 1997-03-04 2001-12-13 Isis Innovation Limited Non-invasive prenatal diagnosis
US20020119118A1 (en) 1997-11-03 2002-08-29 Genentech, Inc. Novel polypeptides and nucleic acids encoding bolekine
CA2702148C (fr) 1999-01-06 2014-03-04 Genenews Inc. Methode de profilage de l'expression genique d'un sujet humain atteint d'une maladie infectieuse
US6762032B1 (en) 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
JP2004510411A (ja) 2000-06-05 2004-04-08 ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー Ｉ型糖尿病の同定およびモジュレーションのための組成物、キット、および方法
ATE375404T1 (de) 2000-06-27 2007-10-15 Von Recklinghausen Ges E V Verfahren zur ermittlung von daten zur präsymptomatischen oder pränatalen diagnose von typ 1 neurofibromatose
US6631330B1 (en) 2000-08-21 2003-10-07 Assistance Publique-Hopitaux De Paris (Ap-Hp) Diagnosis method of inflammatory, fibrotic or cancerous disease using biochemical markers
US6664056B2 (en) 2000-10-17 2003-12-16 The Chinese University Of Hong Kong Non-invasive prenatal monitoring
EP1351707B9 (fr) 2001-01-09 2012-01-25 Baylor Research Institute Traitements de maladies auto-immunes chez un sujet et techniques diagnostiques i in vitro /i
US6753137B2 (en) 2001-01-31 2004-06-22 The Chinese University Of Hong Kong Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma
GB0104690D0 (en) 2001-02-26 2001-04-11 Cytogenetic Dna Services Ltd Diagnostic test
FR2824144B1 (fr) 2001-04-30 2004-09-17 Metagenex S A R L Methode de diagnostic prenatal sur cellule foetale isolee du sang maternel
CA2446666A1 (fr) 2001-05-09 2002-11-14 Biovision Ag Procede pour depister une maladie dementielle chronique evolutive, et peptides et reactifs de depistage associes
US7297556B2 (en) 2001-08-30 2007-11-20 Vermillion, Inc. Method of diagnosing nephrotic syndrome
US6927028B2 (en) 2001-08-31 2005-08-09 Chinese University Of Hong Kong Non-invasive methods for detecting non-host DNA in a host using epigenetic differences between the host and non-host DNA
US20050130245A1 (en) 2001-09-17 2005-06-16 Syn X Pharma, Inc. Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins
US20050095237A1 (en) 2001-12-11 2005-05-05 Emtage Peter C. Methods of therapy and diagnosis using targeting of cells that express P2Y10
US6986995B2 (en) 2002-02-28 2006-01-17 Prometheus Laboratories, Inc. Methods of diagnosing liver fibrosis
US7744876B2 (en) 2002-04-09 2010-06-29 The Curators Of The University Of Missouri Methods and compositions for treatment, prevention, suppression, and/or delaying the onset of type 1 diabetes
US7009038B2 (en) 2002-05-02 2006-03-07 Univ. Of Medicine & Dentistry Of N.J. pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof
US20040009518A1 (en) 2002-05-14 2004-01-15 The Chinese University Of Hong Kong Methods for evaluating a disease condition by nucleic acid detection and fractionation
CA2390820A1 (fr) 2002-06-17 2003-12-17 St. Vincent's Hospital Sydney Limited Methodes de diagnostic, de pronostic et de traitement de maladies cardiovasculaires
EP1520172A1 (fr) 2002-07-05 2005-04-06 EVOTEC Neurosciences GmbH Utilisation diagnostique et therapeutique de proteine et de gene tb2 pour des maladies neurodegeneratives
FR2844279A1 (fr) 2002-09-06 2004-03-12 Inst Nat Sante Rech Med Moyens de detection des processus neurodegeneratifs et leurs applications
US20040141969A1 (en) 2002-09-16 2004-07-22 Juergen Floege Method for the treatment of nephritis using anti-PDGF-DD antibodies
WO2004030522A2 (fr) 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnostic et controle de maladies
US20040086864A1 (en) 2002-10-22 2004-05-06 The Chinese University Of Hong Kong Novel classification methods for pleural effusions
GB0225360D0 (en) 2002-10-31 2002-12-11 Univ London Genetic markers
CA2505416A1 (fr) 2002-11-21 2004-06-10 Wyeth Methodes de diagnostic de rcc et autres tumeurs solides
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
WO2004065629A1 (fr) 2003-01-17 2004-08-05 The Chinese University Of Hong Kong Arnm circulant utilises comme marqueurs diagnostiques pour des troubles de la grossesse
EP1590673B1 (fr) 2003-02-04 2009-04-15 EVOTEC Neurosciences GmbH Utilisation diagnostique de scn2b pour la maladie d'alzheimer
US20080107600A1 (en) 2003-02-13 2008-05-08 Taiichi Katayama Gene Marker And Composition For Diagnosis And Treatment Of Neurological Disorders And Diseases And Use Of The Same
US20040191818A1 (en) 2003-02-26 2004-09-30 O'toole Margot Mary Compositions and methods for diagnosing and treating autoimmune diseases
CA2517802A1 (fr) 2003-03-03 2004-09-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Proteine tyrosine phosphatase-prl-1 en tant que marqueur et cible therateutique pour le cancer du pancreas
JP4717810B2 (ja) 2003-06-20 2011-07-06 ユニバーシティ オブ フロリダ リサーチ ファウンデーション インコーポレイテッド １型糖尿病と２型糖尿病を識別するためのバイオマーカー
DE10333406A1 (de) 2003-07-15 2005-02-10 Protagen Ag T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen
WO2005012907A1 (fr) 2003-08-01 2005-02-10 Renovar, Inc. Systemes et procedes pour caracteriser des maladies renales
WO2005023091A2 (fr) 2003-09-05 2005-03-17 The Trustees Of Boston University Procede de diagnostic prenatal non effractif
US7445886B2 (en) 2003-09-10 2008-11-04 Board Of Regents, The University Of Texas System Macrophage migration inhibitory factor as a marker for cardiovascular risk
CA2539535A1 (fr) 2003-10-03 2005-04-14 Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services Utilisation de cripto-1 en tant que biomarqueur pour maladie neurodegenerative et methode d'inhibition d'une maladie neurodegenerative
EP1689884A4 (fr) 2003-10-08 2007-04-04 Univ Boston Methodes de diagnostic prenatal d'anomalies chromosomiques
ATE435301T1 (de) 2003-10-16 2009-07-15 Sequenom Inc Nicht invasiver nachweis fötaler genetischer merkmale
US7670764B2 (en) 2003-10-24 2010-03-02 Prometheus Laboratories Inc. Methods of diagnosing tissue fibrosis
US20060094064A1 (en) 2003-11-19 2006-05-04 Sandip Ray Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
US20070162983A1 (en) 2003-11-19 2007-07-12 Evotec Neurosciences Gmbh Diagnostic and therapeutic use of the human sgpl1 gene and protein for neurodegenerative diseases
US7598049B2 (en) 2003-11-19 2009-10-06 Satoris, Inc. Methods for diagnosis of Alzheimer's Disease in blood samples
US7939634B2 (en) 2004-01-27 2011-05-10 Compugen Ltd. Polynucleotides encoding polypeptides and methods using same
EP1711633A1 (fr) 2004-02-04 2006-10-18 EVOTEC Neurosciences GmbH Utilisation du gene kcne4 pour diagnostic et therapie, et proteine pour la maladie d'alzheimer
US20050266432A1 (en) 2004-02-26 2005-12-01 Illumina, Inc. Haplotype markers for diagnosing susceptibility to immunological conditions
US8071552B2 (en) 2004-04-05 2011-12-06 Universite Bordeaux 2 Peptides and peptidomimetics binding to CD23
US20080051334A1 (en) 2004-04-16 2008-02-28 Evotec Neurosciences Gmbh Diagnostic and Therapeutic Use of Kcnc1 for Neurodegenerative Diseases
EP2369350B1 (fr) 2004-04-20 2014-08-20 SphingoTec GmbH Utilisation de précurseurs de tachykinines et/ou de fragments de celles-ci dans un diagnostic médical
US20090041862A1 (en) 2004-05-07 2009-02-12 Peter Robert Schofield Detecting disease association with aberrant glycogen synthase kinase 3beta expression
JP2007535959A (ja) 2004-05-10 2007-12-13 エボテツク・ニユーロサイエンシーズ・ゲー・エム・ベー・ハー アルツハイマー病のためのｋｃｎｊ６の診断および治療使用
ES2363156T3 (es) 2004-05-13 2011-07-22 B.R.A.H.M.S Gmbh Uso de precursores de encefalinas y/o sus fragmentos en diagnosis médica.
AU2005243064A1 (en) 2004-05-19 2005-11-24 Harold Wood Hospital ADAM12, a novel marker for abnormal cell function
US7709194B2 (en) 2004-06-04 2010-05-04 The Chinese University Of Hong Kong Marker for prenatal diagnosis and monitoring
JP2008505649A (ja) 2004-07-09 2008-02-28 アモークス リミテッド 免疫細胞バイオセンサーおよびその使用方法
WO2006020269A2 (fr) 2004-07-19 2006-02-23 University Of Rochester Biomarqueurs de maladie neurodegenerative
JP2008514900A (ja) 2004-07-30 2008-05-08 アデザ・バイオメデイカル・コーポレイシヨン 疾病および他の状態のマーカーとしての癌胎児性フィブロネクチンならびに癌胎児性フィブロネクチンの検出のための方法
WO2006020899A2 (fr) 2004-08-13 2006-02-23 Metrigenix Corporation Marqueurs pour la detection de maladies auto-immunes
US20070087376A1 (en) 2004-08-30 2007-04-19 Potashkin Judith A Splice variants of pre-mRNA transcripts as biomarkers in idiopathic neurodegenerative diseases
US7595159B2 (en) 2004-11-03 2009-09-29 The Brigham And Women's Hospital, Inc. Prediction of Parkinson's disease using gene expression levels of peripheral blood samples
WO2006048778A1 (fr) 2004-11-08 2006-05-11 King's College London Marqueurs de la predisposition a des etats de dependance
US20060115855A1 (en) 2004-12-01 2006-06-01 Power3 Medical Products, Inc. FK506-binding protein 7 related protein as a biomarker for neurodegenerative disease
US20060115854A1 (en) 2004-12-01 2006-06-01 Power3 Medical Products, Inc. Acetyl-LDL receptor related proteins and peptides as a biomarker for neurodegenerative disease
GB0426859D0 (en) 2004-12-07 2005-01-12 Proteome Sciences Plc Diagnosis of neurodegenerative disorders
CA2590781A1 (fr) 2004-12-07 2006-06-15 Electrophoretics Limited Diagnostic de maladies neurodegeneratives
AU2005313971B2 (en) 2004-12-08 2011-10-13 Immunomedics, Inc. Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
CN101120021A (zh) 2004-12-31 2008-02-06 基因技术公司 结合br3的多肽及其用途
FR2880897B1 (fr) 2005-01-18 2010-12-17 Inst Nat Sante Rech Med Methode de detection, non invasive, prenatale, in vitro de l'etat sain normal, de l'etat de porteur sain ou de l'etat de porteur malade de la mucoviscidose
US7432107B2 (en) 2005-01-24 2008-10-07 Roche Diagnostics Operations, Inc. Cardiac hormones for assessing cardiovascular risk
US7572592B2 (en) 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
US20070141625A1 (en) 2005-02-03 2007-06-21 Santos Jose H Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies
ITRM20050067A1 (it) 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici virali o di origine virale nelle urine.
US7666595B2 (en) 2005-02-25 2010-02-23 The Brigham And Women's Hospital, Inc. Biomarkers for predicting prostate cancer progression
US7645576B2 (en) 2005-03-18 2010-01-12 The Chinese University Of Hong Kong Method for the detection of chromosomal aneuploidies
CA3007182A1 (fr) 2005-03-18 2006-09-21 The Chinese University Of Hong Kong Marqueurs de diagnostic prenatal, de surveillance ou de prediction de lapreeclampsie
US20060257901A1 (en) 2005-03-24 2006-11-16 Beth Israel Deaconess Medical Center Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
EP2146209B1 (fr) 2005-04-06 2011-11-16 University of Antwerp Marqueurs neuro-dégénératifs pour la maladie d'Alzheimer
WO2006111946A2 (fr) 2005-04-18 2006-10-26 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Polypeptides et utilisation de ceux-ci
WO2006114661A1 (fr) 2005-04-26 2006-11-02 Dwek Raymond A Analyse de glycane a haut rendement pour diagnostiquer et surveiller l'arthrite rhumatoide et d'autres maladies auto-immunes
WO2006121952A2 (fr) 2005-05-05 2006-11-16 The Regents Of The University Of California Biomarqueurs de diagnostic de troubles neurologiques du developpement
JP5421590B2 (ja) 2005-05-18 2014-02-19 ノバルティス アーゲー 自己免疫および／または炎症性成分を有する疾患の診断および治療のための方法
GB0512401D0 (en) 2005-06-17 2005-07-27 Randox Lab Ltd Method
GB2428240A (en) 2005-07-14 2007-01-24 Univ Gen Ve Diagnostic method for brain damage-related disorders
US20070148661A1 (en) 2005-07-19 2007-06-28 Duke University LSAMP Gene Associated With Cardiovascular Disease
US20070218469A1 (en) 2005-10-03 2007-09-20 Ruth Navon Novel mutations in hexosaminidase A
IL172297A (en) 2005-10-03 2016-03-31 Compugen Ltd Soluble vegfr-1 variants for diagnosis of preeclamsia
CA2625744A1 (fr) 2005-10-11 2007-04-19 Tethys Bioscience, Inc. Marqueurs associes au diabete et procedes d'utilisation de ceux-ci
WO2007047907A2 (fr) 2005-10-14 2007-04-26 The Regents Of The University Of Michigan Compositions de proteines dek et methodes d'utilisation de celles-ci
TW200726845A (en) 2006-01-02 2007-07-16 Nat Defense Medical Ct Biomarker molecular of renal illness and detecting method for the same
EP1808694A1 (fr) 2006-01-17 2007-07-18 Universitätsklinikum Freiburg Procédé de diagnostic d'une maladie polykystique des reins
FR2896588B1 (fr) 2006-01-20 2016-08-19 Univ D'angers Methode de diagnostic in vitro de reponse immunitaire autoimmune par detection d'anticorps diriges contre l'antigene pentraxine 3.
EP1987361A4 (fr) 2006-01-30 2009-03-04 Invitrogen Corp Compositions et procédé pour détecter et quantifier des substances toxiques dans des états pathologiques
US7459280B2 (en) 2006-02-27 2008-12-02 Picobella, Llc Methods for diagnosing and treating kidney cancer
CA2689848A1 (fr) 2006-02-28 2007-09-07 Phenomenome Discoveries Inc. Methodes permettant de diagnostiquer la demence et autres troubles neurologiques
US7488584B2 (en) 2006-03-24 2009-02-10 Picobella Methods for diagnosing and treating kidney and colorectal cancer
US20070224638A1 (en) 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
GB0606776D0 (en) 2006-04-03 2006-05-10 Novartis Pharma Ag Predictive biomarkers for chronic allograft nephropathy
EP1847615A1 (fr) 2006-04-18 2007-10-24 Genoscreen Expression et polymorphisme du gène transcarbamylase d'ornithine (OTC) comme marqueurs diagnostiques de la maladie d'Alzheimer
US7662578B2 (en) 2006-04-21 2010-02-16 Children's Hospital Medical Center Method and kit for the early detection of impaired renal status
EP2021799B1 (fr) 2006-04-27 2011-07-20 Critical Care Diagnostics, Inc. Interleukine-33 (il-33) utilisée pour le diagnostic et le pronostic des maladies cardiovasculaires
PT2021796E (pt) 2006-05-01 2012-04-19 Critical Care Diagnostics Inc Diagnóstico de doença cardiovascular
US7901884B2 (en) 2006-05-03 2011-03-08 The Chinese University Of Hong Kong Markers for prenatal diagnosis and monitoring
US7754428B2 (en) 2006-05-03 2010-07-13 The Chinese University Of Hong Kong Fetal methylation markers
JP5210156B2 (ja) 2006-05-12 2013-06-12 学校法人慶應義塾 炎症性疾患の検出並びに炎症性疾患の予防又は治療用組成物
WO2007131345A1 (fr) 2006-05-12 2007-11-22 The Hospital For Sick Children Facteur de risque génétique dans les gènes sod1 et sfrs15 dans la néphropathie, la cataracte diabétique, la maladie cardiovasculaire et la longévité
PL2018184T3 (pl) 2006-05-17 2013-12-31 The Ludwig Institute For Cancer Res Przeciwciało Anty-VEGF-B do stosowania w leczeniu lub profilaktyce cukrzycy typu II lub zespołu metabolicznego
WO2007139895A2 (fr) 2006-05-24 2007-12-06 Cellumen, Inc. Procédé de modélisation d'une maladie
US20080038269A1 (en) 2006-05-25 2008-02-14 Mount Sinai Hospital Methods for detecting and treating kidney disease
DE102006027818A1 (de) 2006-06-16 2007-12-20 B.R.A.H.M.S. Aktiengesellschaft In vitro Multiparameter-Bestimmungsverfahren zur Diagnose und Frühdiagnose von neurodegenerativen Erkrankungen
WO2008084331A2 (fr) 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarqeurs pour des troubles rénaux
WO2008003826A1 (fr) 2006-07-07 2008-01-10 Oy Jurilab Ltd Nouveaux gènes et marqueurs dans l'hypertension arterielle essentielle
KR100856375B1 (ko) 2006-07-18 2008-09-04 김현기 퇴행성 신경질환 진단용 마커
US7851172B2 (en) 2006-07-25 2010-12-14 University Of Kentucky Research Foundation Biomarkers of mild cognitive impairment and alzheimer's disease
US20080026378A1 (en) 2006-07-28 2008-01-31 Gian Franco Bottazzo Prediction and prophylactic treatment of type 1 diabetes
US20080113358A1 (en) 2006-07-28 2008-05-15 Ravi Kapur Selection of cells using biomarkers
ITTO20060614A1 (it) 2006-08-21 2008-02-22 Uni Degli Studi Del Piemonte "diagnosi differenziale per la sclerodermia"
WO2008028257A1 (fr) 2006-09-08 2008-03-13 Garvan Institute Of Medical Research diagnostics et thérapeutiques d'une maladie neurologique
CN101529248A (zh) 2006-09-14 2009-09-09 佐拉生物科学有限公司 作为用于早期预测自身免疫和1型糖尿病风险之工具的生物流体代谢物谱分析
EP1905841A1 (fr) 2006-09-25 2008-04-02 Max Delbrück Centrum für Molekulare Medizin (MDC) Berlin-Buch; Trex1 comme marqueur du lupus érythemateux
WO2008037449A2 (fr) 2006-09-26 2008-04-03 Proteosys Ag Utilisation d'au moins une isoforme du composant 1 de la membrane du récepteur de la progestérone (pgrmc1)
US8110365B2 (en) 2006-10-05 2012-02-07 Rhode Island Hospital Compositions and methods for detecting and treating renal injury and inflammation
WO2008043725A1 (fr) 2006-10-10 2008-04-17 Novartis Ag Biomarqueur utilisé dans des affections inflammatoires
US20100029007A1 (en) 2006-10-11 2010-02-04 Novaartis Ag Biomarker in Inflammatory Diseases
WO2008046510A1 (fr) 2006-10-16 2008-04-24 Bayer Healthcare Ag Fn1 utilisé comme biomarqueur, cible thérapeutique et diagnostique
EP2087359A1 (fr) 2006-10-16 2009-08-12 Bayer Schering Pharma AG Prss23 utilisée comme biomarqueur, cible thérapeutique et diagnostique
WO2008046509A1 (fr) 2006-10-16 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Protéine ltbp2 utilisée en tant que biomarqueur, cible thérapeutique et diagnostique
WO2008046511A1 (fr) 2006-10-16 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Crtac utilisé comme biomarqueur, cible thérapeutique et diagnostique
US20080261217A1 (en) 2006-10-17 2008-10-23 Melnikov Anatoliy A Methylation Profile of Cancer
WO2008046160A1 (fr) 2006-10-20 2008-04-24 Newcastle Innovation Limited Méthode de détection de biomarqueurs associés à des états liés à la grossesse
WO2008063369A2 (fr) 2006-11-01 2008-05-29 George Mason Intellectual Properties, Inc. Biomarqueurs pour états neurologiques
JP2010510528A (ja) 2006-11-22 2010-04-02 ライフ テクノロジーズ コーポレーション 自己免疫疾患のバイオマーカー
US20100169988A1 (en) 2006-12-06 2010-07-01 Bernhard Kohli Means and methods for isolating and determining novel targets for the treatment of neurodegenerative, neurological or neuropsychiatric disorders and compositions comprising the same
IL180095A0 (en) 2006-12-14 2007-05-15 Ohad Birk Method for antenatal estimation of down syndrome risk
US8362224B2 (en) 2006-12-19 2013-01-29 The Trustees Of The University Of Pennsylvania Screening for CD93 (C1qRp)-associated polymorphism(S) in the diagnosis, prevention and treatment of autoimmune diseases
US8815519B2 (en) 2006-12-22 2014-08-26 Hvidovre Hospital Method for predicting cancer and other diseases
AU2007342674B2 (en) 2007-01-10 2013-09-19 Purdue Research Foundation Polypeptide inhibitors of HSP27 kinase and uses therefor
WO2008085024A1 (fr) 2007-01-12 2008-07-17 Erasmus University Medical Center Rotterdam Identification et détection de peptides associés à des troubles spécifiques
US8058015B2 (en) 2007-01-22 2011-11-15 Medizinische Universität Innsbruck Markers for chronic kidney disease
AU2008213742A1 (en) 2007-02-08 2008-08-14 Powmri Limited Method of diagnosing a neurodegenerative disease
US20080261226A1 (en) 2007-02-15 2008-10-23 Rengang Wang Biomarkers of neurodegenerative disease
HUE030996T2 (en) 2007-02-21 2017-06-28 Decode Genetics Ehf Coronary artery disease and myocardial infarction
WO2008112772A2 (fr) 2007-03-14 2008-09-18 Baylor Research Institute Expression génique dans des cellules sanguines mononucléaires périphériques d'enfants diabétiques
CA2682516A1 (fr) 2007-03-26 2008-10-02 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Isoforme du kcnh2 associe a la schizophrenie et developpement de medicaments antipsychotiques
EP1975252A1 (fr) 2007-03-29 2008-10-01 INSERM (Institut National de la Santé et de la Recherche Medicale) Procédés pour le pronostic ou le diagnostic d'une maladie thyroïdienne
US20120052592A9 (en) 2007-03-30 2012-03-01 Nano Solution, Inc., Method for determining prognosis of acute central nervous system disorder
EP2145182A2 (fr) 2007-04-12 2010-01-20 Apitope International NV Biomarqueurs pour la sclérose en plaques
GB0707933D0 (en) 2007-04-24 2007-05-30 Apitope Technology Bristol Ltd Disease markers
GB0708075D0 (en) 2007-04-26 2007-06-06 Univ Nottingham Nethods
EP2162459B1 (fr) 2007-05-01 2017-10-04 University of Miami Biomarqueurs transcriptomiques pour évaluation de risque individuel de nouvelle survenue d'insuffisance cardiaque
CA2686861A1 (fr) 2007-05-03 2008-11-13 Medimmune, Llc Marqueurs pharmacodynamiques alpha-induit d'interferon
WO2008147938A2 (fr) 2007-05-24 2008-12-04 Centocor, Inc. Wnt5a utilise en tant que marqueur des maladies inflammatoires
JP5661457B2 (ja) 2007-06-06 2015-01-28 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． 腎疾患の予測診断
EP2158326B1 (fr) 2007-06-21 2012-06-20 The Board of Trustees of The Leland Stanford Junior University Biomarqueurs de la polyarthrite rhumatoïde
ITRM20070351A1 (it) 2007-06-22 2008-12-23 Istituto Naz Per Le Malattie I Gene codificante la proteina ambra 1 avente attivita' regolatoria dell autofagia e dello sviluppo del sistema nervoso centrale
US20110212075A1 (en) 2007-06-25 2011-09-01 Siemens Aktiengesellschaft Screening method for polymorphic markers in htra1 gene in neurodegenerative disorders
WO2009003142A1 (fr) 2007-06-27 2008-12-31 The Board Of Trustees Of The Leland, Stanford Junior University Bêta-2-microglobuline et protéine c réactive (crp) en tant que biomarqueurs pour une maladie artérielle périphérique
CN101801462A (zh) 2007-07-13 2010-08-11 健泰科生物技术公司 用于癌症、炎性病症和自身免疫性病症的治疗和诊断
CA2690541A1 (fr) 2007-07-17 2009-01-29 Metabolon, Inc. Biomarqueurs du prediabete, des maladies cardiovasculaires et d'autres troubles lies au syndrome metabolique, et methodes d'utilisation de ces biomarqueurs
US20110081649A1 (en) 2007-08-02 2011-04-07 Iss Immune System Stimulation Ab Diagnosis, staging and monitoring of inflammatory bowel disease
US9086425B2 (en) 2007-08-29 2015-07-21 The Cleveland Clinic Foundation Carbamylated proteins and risk of cardiovascular disease
US20090275046A1 (en) 2007-08-29 2009-11-05 Power3 Medical Products, Inc. Complement factor H protein as a biomarker of Parkinson's disease
US8748100B2 (en) 2007-08-30 2014-06-10 The Chinese University Of Hong Kong Methods and kits for selectively amplifying, detecting or quantifying target DNA with specific end sequences
GB0717637D0 (en) 2007-09-10 2007-10-17 Univ Leiden Future cardiac event biomarkers
US8062852B2 (en) 2007-10-01 2011-11-22 The Children's Hospital And Regional Medical Center Detection and treatment of autoimmune disorders
ITUD20070183A1 (it) 2007-10-01 2009-04-02 Univ Degli Studi Udine Metodo diagnostico e prognostico per la diagnosi e la prognosi della linfoproliferazione nelle malattie autoimmuni
US20110212076A1 (en) 2007-10-15 2011-09-01 King's College London Viral Therapeutic
EP2212693B1 (fr) 2007-10-22 2015-04-22 The Regents of The University of California Biomarqueurs pour un diagnostic prénatal de cytomégalovirus congénital
FI20070795A0 (fi) 2007-10-24 2007-10-24 Faron Pharmaceuticals Oy Uusi biomarkkeri sairauksien kehittämisen tarkkailuun ja terapioiden tehon arviointiin
WO2009053537A1 (fr) 2007-10-26 2009-04-30 Biohit Oyj Méthodes et produits pour diagnostiquer des maladies auto-immunes et un cancer gastrique lié à une gastrite atrophique
WO2009059259A2 (fr) 2007-10-31 2009-05-07 Children's Hospital Medical Center Détection de l'aggravation d'une pathologie rénale chez des sujets atteints de lupus érythémateux disséminé
WO2009058168A1 (fr) 2007-11-04 2009-05-07 Prediction Sciences Llc Fibronectine cellulaire en tant que marqueur de diagnostic dans une maladie cardiovasculaire et ses procédés d'utilisation
JP2011515068A (ja) 2007-11-08 2011-05-19 ノバルティス アーゲー 慢性／硬化性同種移植腎症に対する遺伝子発現シグネチャー
WO2009065132A1 (fr) 2007-11-16 2009-05-22 Oklahoma Medical Research Foundation Prédiction et diagnostic de patients atteints d'une maladie auto-immune
US20100255485A1 (en) 2007-11-28 2010-10-07 Pico Caroni Biomarkers for the onset of neurodegenerative diseases
US8506933B2 (en) 2007-11-30 2013-08-13 Msdx, Inc. Methods of detecting a neurological condition via analysis of circulating phagocytes
WO2009074331A2 (fr) 2007-12-11 2009-06-18 Julius-Maximilians-Universität Würzburg Test diagnostique precoce et differentiel de la maladies d'alzheimer
WO2009075566A1 (fr) 2007-12-12 2009-06-18 Erasmus University Medical Center Rotterdam Biomarqueurs pour maladie cardiovasculaire
EP2075343A1 (fr) 2007-12-21 2009-07-01 Gert Mayer Procédé pour diagnostiquer une maladie progressive
EP2240601B1 (fr) 2007-12-27 2016-10-12 Compugen Ltd. Biomarqueurs pour prévoir l'apparition d'une lésion rénale
MX340916B (es) * 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
WO2009092382A1 (fr) 2008-01-23 2009-07-30 Rigshospitalet, Region Hovedstaden Classification d’individus souffrant de maladies cardiovasculaires selon des pronostics de survie tels que découverts en mesurant les concentrations du biomarqueur ykl-40
US20090299155A1 (en) 2008-01-30 2009-12-03 Dexcom, Inc. Continuous cardiac marker sensor system
WO2009100131A2 (fr) 2008-02-04 2009-08-13 Banyan Biomarkers, Inc. Processus pour diagnostiquer ou traiter les lésions cérébrales
KR20110005783A (ko) 2008-02-08 2011-01-19 메디뮨 엘엘씨 질환 마커 및 그의 용도
US20090239242A1 (en) 2008-03-18 2009-09-24 Biotrin Intellectual Properties Limited Method for the early identification and prediction of kidney injury
CA2646040A1 (fr) 2008-03-22 2009-09-22 David V. Pow Detection de biomarqueur de cellules aberrantes d'origine neuroectodermale dans un liquide corporel
GB0809069D0 (en) 2008-05-19 2008-06-25 Univ Leuven Kath Gene signatures
WO2009122387A1 (fr) 2008-04-04 2009-10-08 Biotrin Group Ltd. Procédé de détection et de prédiction de maladie rénale associée à l’obésité
EP2107377A1 (fr) 2008-04-04 2009-10-07 BRAHMS Aktiengesellschaft Niveaux pro-endothéline 1 pour la prédiction d'un risque d'événements tachyarrhytmiques
WO2009126271A1 (fr) 2008-04-11 2009-10-15 China Synthetic Rubber Corporation Procédés, agents et trousses pour le dépistage du cancer
EP2279270B1 (fr) 2008-04-15 2014-06-18 Oberbauer, Rainer Marqueurs de l'insuffisance rénale aiguë
US8030097B2 (en) 2008-04-30 2011-10-04 Versitech Limited and R & C Biogenius Limited Lipocalin-2 as a prognostic and diagnostic marker for heart and stroke risks
WO2010005750A2 (fr) 2008-06-16 2010-01-14 The Regents Of The University Of California Marqueurs pronostics et cibles thérapeutiques potentiels pour troubles neurologiques
US20100167937A1 (en) 2008-07-08 2010-07-01 Power3 Medical Products, Inc. Multiple forms of Alzheimer's disease based on differences in concentrations of protein biomarkers in blood serum
EP2853601B1 (fr) 2008-07-18 2016-09-21 TrovaGene, Inc. Procédés de détection à base de PCR de séquences d'acide nucléique ultracourt
US20110177509A1 (en) 2008-07-23 2011-07-21 The Washington University Risk factors and a therapeutic target for neurodegenerative disorders
JP2011529453A (ja) 2008-07-31 2011-12-08 ホスピタル クリニク アイ プロビンシアル デ バルセロナ 健康な腎臓のバイオマーカ
JP5781436B2 (ja) 2008-08-11 2015-09-24 バンヤン・バイオマーカーズ・インコーポレーテッド 神経学的状態のバイオマーカー検出方法およびアッセイ
ES2341419B1 (es) 2008-08-14 2011-05-03 Hospital Clinic I Provincial De Barcelona Wnt1 como biomarcador de daño renal.
US8673574B2 (en) 2008-08-21 2014-03-18 Pxbiosciences Llc Diagnosis and monitoring of renal failure using peptide biomarkers
CA2735590A1 (fr) 2008-08-29 2010-03-04 Astute Medical, Inc. Procedes et compositions pour le diagnostic et le pronostic de la blessure renale et de l'insuffisance renale
MX2011003352A (es) 2008-09-30 2011-05-02 Genentech Inc Marcadores biologicos predictivos de la respuesta de la artritis reumatoide a antagonistas de linfotoxina.
US20100124756A1 (en) 2008-10-10 2010-05-20 Sandip Ray Collection of biomarkers for diagnosis and monitoring of alzheimer's disease in body fluids
GB0818650D0 (en) 2008-10-10 2008-11-19 Uni I Oslo Methods
WO2010048347A2 (fr) 2008-10-21 2010-04-29 Astute Medical, Inc. Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d’insuffisance rénale
NZ607703A (en) 2008-10-21 2014-09-26 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2180322A1 (fr) 2008-10-22 2010-04-28 BRAHMS Aktiengesellschaft Biomarqueurs de pronostic pour la progression d'une maladie de reins chroniques primaires
CA2741114A1 (fr) 2008-10-24 2010-04-29 Cornelis Lammert Verweij Biomarqueurs pour predire le developpement de maladies auto-immunes chroniques
WO2010048497A1 (fr) 2008-10-24 2010-04-29 Genizon Biosciences Inc. Profil génétique des marqueurs associés à la maladie d'alzheimer
EP2352502A4 (fr) 2008-11-06 2012-12-26 Univ Miami Protéolyse limitée de la cd2ap et évolution d'une maladie rénale
EP2364368B1 (fr) 2008-11-07 2014-01-15 Sequenta, Inc. Procédés de surveillance de maladies par analyse de séquence
CN102264230B (zh) 2008-11-10 2014-12-10 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
CN102209894A (zh) 2008-11-11 2011-10-05 安特鲁斯公司 用于评价动脉粥样硬化潜在性的生物标记
US20120094295A1 (en) 2008-11-21 2012-04-19 The Johns Hopkins University Neurodegenerative disease diagnostic compositions and methods of use
MX2011005379A (es) 2008-11-22 2011-06-09 Astute Medical Inc Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
IT1392551B1 (it) 2008-11-25 2012-03-09 Bioindustry Park Del Canavese S P A Biomarcatori per la diagnosi e per rilevare la progressione di malattie neurodegenerative, in particolare della sclerosi laterale amiotrofica
CN102308212A (zh) 2008-12-04 2012-01-04 加利福尼亚大学董事会 用于确定前列腺癌诊断和预后的材料和方法
EP2373999A4 (fr) 2008-12-09 2012-11-07 Stephanie Fryar-Williams Nouveaux biomarqueurs
ES2706403T3 (es) 2008-12-10 2019-03-28 Joslin Diabetes Center Inc Métodos para diagnosticar y predecir una enfermedad renal
WO2012012714A2 (fr) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Méthodes de dépistage de maladies ou d'affections neurologiques ou neuropsychiatriques
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
EP2596132A4 (fr) 2010-07-23 2013-12-18 Harvard College Procédés de détection de signatures de maladies ou pathologies dans des liquides biologiques
CA2806296A1 (fr) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Procedes de detection de maladies ou d'etats associes au rein
AU2011281012A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting cardiovascular diseases or conditions
US20120258878A1 (en) 2010-08-04 2012-10-11 Med Biogene Inc. Prognostic gene signatures for non-small cell lung cancer
WO2012031008A2 (fr) * 2010-08-31 2012-03-08 The General Hospital Corporation Matières biologiques liées au cancer dans des microvésicules
EP2678448A4 (fr) 2011-02-22 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L Biomarqueurs circulants
AU2012275500A1 (en) * 2011-06-27 2014-01-16 Dana-Farber Cancer Institute, Inc. Signatures and determinants associated with prostate cancer progression and methods of use thereof
JP2015522260A (ja) * 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
EP2885428B1 (fr) * 2012-08-17 2017-05-03 Memorial Sloan-Kettering Cancer Center Profil d'expression génique associé au cancer de la prostate
US10015273B2 (en) 2014-07-29 2018-07-03 Open Text Sa Ulc Extensible provider connection systems, methods and architecture
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014164362A1 (fr) * 2013-03-09 2014-10-09 Harry Stylli Procédés de détection du cancer de la prostate
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
US9548919B2 (en) 2014-10-24 2017-01-17 Cisco Technology, Inc. Transparent network service header path proxies

Also Published As

Publication number Publication date
EP4075139A1 (fr) 2022-10-19
EP4428251A3 (fr) 2024-12-18
WO2016040843A1 (fr) 2016-03-17
US20170275704A1 (en) 2017-09-28
EP3191846A1 (fr) 2017-07-19
US10626464B2 (en) 2020-04-21
EP3693742A3 (fr) 2020-09-02
EP4428251A2 (fr) 2024-09-11
AU2015314813B2 (en) 2022-02-24
AU2022203356A1 (en) 2022-06-09
EP3693742A2 (fr) 2020-08-12
US12529109B2 (en) 2026-01-20
EP4075139B1 (fr) 2024-05-22
EP3191846A4 (fr) 2018-06-13
EP3693742B1 (fr) 2022-04-06
US20200318201A1 (en) 2020-10-08
AU2015314813A1 (en) 2017-04-06

Similar Documents

Publication Publication Date Title
EP3194624A4 (fr) Méthodes pour le diagnostic, le pronostic et la surveillance du cancer du sein et réactifs correspondants
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
EP3156498A4 (fr) Kit ou dispositif de détection du cancer du sein, et procédé de détection du cancer du sein
DK3425055T3 (da) Molekylært detekterings-/diagnosereagens til tumor
EP3119908A4 (fr) Détermination de l'agressivité d'un cancer, de son pronostic et de sa sensibilité à un traitement
MX2020002831A (es) Metodos y procesos para evaluacion no invasiva de variaciones geneticas.
EP4513187A3 (fr) Procédés de detection du cancer de la prostate
EA201691952A1 (ru) Композиции и методы, имеющие отношение к диагностике рака предстательной железы
MX2017005888A (es) Dispositivos, sistemas y metodos para la deteccion de analitos.
EP4202441A3 (fr) Profil d'expression génétique dans les macrophages pour le diagnostic du cancer
MA40636A (fr) Procédés pour détecter le cancer de la prostate
IL254687B1 (en) A bio-sensor system for rapid identification of an analyte
IL254119A0 (en) Blood-based mrna markers for prostate cancer prediction and methods for its detection
EP3204008A4 (fr) Utilisation de biomarqueurs permettant de prédire la sensibilité clinique pour le traitement du cancer
IL249579B (en) Methods for treating, diagnosing and prognosing a haematological malignancy
MX388832B (es) Deteccion especifica de isoformas de clusterina.
EP4400600A3 (fr) Procédés pour détecter plusieurs acides nucléiques dans un échantillon
PT3229830T (pt) Métodos de tratamento e prognóstico de tumores malignantes não hematopoieticos
EP3189332A4 (fr) Biomarqueurs pour la détection du cancer du sein
HK1241463A1 (en) Methods of detecting prostate cancer
AU2014903680A0 (en) Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor
TH1501006632A (th) อุปกรณ์การเก็บและสอบวิเคราะห์ตัวอย่างของไหลของร่างกาย
TH1601001795B (th) วิธีสำหรับการตรวจวัดและกำหนดหาปริมาณของกาแลคโต-โอลิโกแซคคาไรด์
UA93433U (uk) Спосіб визначення оксидантно-антиоксидантної системи крові за умов водного та сольового навантаження